Cell cultures for COVID-19 high-throughput drug development

We are proud to announce our participation in the new public-private partnership project “CLEAR COVID-19,” funded by Health Holland. Together with University Medical Center Utrecht (UMCU), First Health Pharmaceuticals, QVQ Holding B.V., and Vossensteyn Biomedical, we will help develop nasal airway epithelial cell cultures for high-throughput drug development. The focus of the project is to…

Read more

Welcome to our new website!

We are very excited to announce the launch of our new website. We’ve made the site faster, easier to navigate, and incorporated a fresh design. Thanks to the outstanding pictures from our labs, offices, and the team, the site feels more personal. Furthermore, we have drastically improved the information on our services and technologies. Find…

Read more

Stijn, welcome to the team!

We are pleased to announce that as of August 1st, Stijn Emmelot has joined the team as Marketing Intern. At Single Cell Discoveries, Stijn will be responsible for investigating the state of the market of single-cell sequencing and efficiently reporting this information back to the team. Stijn completed his bachelors degree in Biomedical Sciences and…

Read more

BioTuring and Single Cell Discoveries data vizualization partnership

Do you want to quickly and intuitively analyze your single-cell sequencing data, and export your results without having to know how to code? Single Cell Discoveries and BioTuring have set up a partnership to make BioTuring’s single-cell browser available to Single Cell Discoveries’ customers. You can request a license to use the browser when you…

Read more

Celebrating 2 years of single-cell sequencing services

It has been two years since we generated single-cell sequencing libraries for our first customer on June 11, 2018. We have had a great start: we grew from just 2 founders to a team to 10, have processed more than 1 million cells, and serviced customers in 12 different countries (and counting). See the infographic below…

Read more